Abstract
sequences of variants recovered from infected individuals in different risk groups for infection
and from different geographical regions has revealed the existence of six major genetic groups, called genotypes. 2 Each of these six genotypes consists of a series of more closely related subtypes, differing in nucleotide sequence by 20 to 25%, whereas differences of more than 30% are observed between genotypes. 2 Most HCV-associated liver injury results from the host immune response, 3 but some pathological features, such as liver steatosis, are compatible with direct viral cytopathic effects contributing to disease progression. 4 5 Steatosis involves the deposition of triglycerides in the liver and constitutes a major determinant of the progression of fibrosis in patients with chronic hepatitis. 6 7 Liver steatosis may be related to host metabolic factors (excess weight, diabetes, hyperlipidaemia, excessive alcohol intake), [8] [9] [10] but many studies have clearly demonstrated a significant association between HCV genotype 3 infection and the presence of steatosis. [11] [12] [13] [14] The prevalence and severity of steatosis are higher in patients infected with HCV of genotype 3 than in patients infected with other HCV genotypes. In patients infected with genotype 3 viruses, fat accumulation in the liver is correlated with the level of HCV replication in the serum 13 and liver 9 , and disappears following successful antiviral therapy. 14 15 Conversely, most cases of mild steatosis in patients infected with other genotypes seem to be metabolic in origin, with excess weight being the most significant clinical correlate. 16 Steatosis usually persists following successful antiviral therapy in patients infected with a non-genotype 3 HCV. 15 17 These clinical observations suggest that specific genotype 3 HCV products may be involved in liver steatosis.
In vitro studies have shown that HCV core protein can associate with lipid droplets acting as intracellular storage sites for triacylglycerols and cholesterol esters. [18] [19] [20] [21] Two lines of transgenic mice producing HCV core protein exclusively in the liver develop steatosis, followed by hepatocellular carcinoma. 22 23 Until recently, 24 studies on HCV core protein production were based on the use of constructs derived from isolates of HCV genotype 1. We have established a model based on Semliki forest virus (SFV) replicon vectors, which can be used to produce HCV core protein in mammalian cells, leading to the assembly of this protein into HCV-like particles. [25] [26] [27] Although this cellular model is based on HCV core protein production from a genotype 1a virus, it also displays the accumulation and clustering of lipid droplets in the perinuclear area of transfected cells, mimicking HCV core protein-associated steatosis in vitro. 27 We therefore studied the role of HCV genotype in steatosis, by investigating whether the production of a core protein bearing residues specific to HCV genotype 3 increased lipid droplet clustering and accumulation in this in vitro cellular model.
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METHODS
Sequence alignment and construct design
The HCV core protein has three domains, based on predicted structural and functional characteristics ( fig. 1 ). 20 28 1A ). We therefore decided to replace Y164 by F in a core protein sequence from an HCV 1a genotype.
The HCV core 1a construct was obtained from our previously described 25 1B) . PCR was carried out with the Pfu Turbo DNA polymerase (Stratagene, La Jolla CA). DNA sequencing was used to check that the original sequence was conserved in both constructs, and that the Y164F mutation had been correctly introduced.
Cell culture and RNA transfection
Baby hamster kidney cells (BHK-21) were cultured and electroporated with recombinant SFV RNA encoding the HCV core 1a or 1aY164F proteins, as previously described. [25] [26] [27] Briefly, cells were cultured at 37°C in Glasgow Minimal Essential Medium Cells were cultured for 16 h following electroporation, as our previous studies have shown that the major morphological events associated with HCV structural protein production occur during this period in this system. 25 26 In some experiments, HCV core proteins were produced in BHK-21 cells in the presence of 100 µM of (Z-LL) 2 -ketone (Calbiochem), an inhibitor of SPP. 27 All experiments were conducted with BHK-21 cells, except for confocal microscopy studies of the subcellular distribution of core proteins. For these studies, we transfected the human hepatocellular carcinoma cell line FLC4 under similar conditions. The lower efficiency of the SFV vectors in these cells resulted in the production of smaller amounts of protein than in BHK-21 cells, allowing a more precise analysis of the subcellular distribution of proteins. 27 
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Western blotting BHK-21 cells were lysed in a buffer containing protease inhibitors as previously described. [25] [26] [27] Samples were then separated by SDS-PAGE in 15 % polyacrylamide gels and the resulting bands were transferred to a polyvinylidene difluoride membrane. antibodies without prior incubation with primary antibody to check that the reaction was specific. Ultrathin sections were stained and observed as described above.
For each construct (-Gal, core 1a, core 1aY164F), the number and diameter (in m)
of lipid droplets was determined on the computer screen for 100 consecutive EM (standard)
sections of the transfected cells. All investigations were conducted blind, with the encoded EM grids examined in random order. Lipid droplet diameter was converted into an area in m 2 . By summing these areas, we were able to determine the cumulative lipid droplet area, in m 2 , for each cell section.
Statistical analysis
Lipid droplet areas in 100 consecutive EM sections of the transfected cells seemed to follow mixed distributions. Indeed, the probability of observing a null area (discrete component of the distribution) was non-null, whereas a probability density function existed for all non-zero values of cumulative areas (continuous component of the distribution). We therefore decided to categorise the variable before carrying out statistical tests. Based on Sturges' rule, we defined seven classes of cumulative lipid droplet area (0 m 2 ; 0-0.5 m 2 ; 0.5-1 m 2 ; 1-2 m 2 ;
2-3 m 2 ; 3-5 m 2 and >5 m 2 ), thereby defining an ordinal variable. Constructs were compared, using a global chi-squared test, followed by chi-squared tests for trend, taking into account the ordinal nature of the newly created variables. Data were analysed with SAS 9.1 software.
RESULTS
Expression and processing of HCV core 1a and 1aY164F proteins inserm-00167783, version 1 -23 Aug 2007
Sixteen hours after transfection with the constructs encoding HCV core proteins or the -gal control, the cells were harvested and lysed for western-blot analysis ( fig. 2A) . Consistent with our previous findings, 26 27 the core 1a protein encoded by the Dj6.4 sequence was efficiently cleaved by SPP ( fig. 2A line 2 ). As this cleavage leads to the removal of a short domain, it is difficult to discriminate between the cleaved and uncleaved forms of the HCV core protein on western blots. 31 We therefore used cells expressing the core 1a construct and treated with (Z-LL) 2 -ketone, a commercially available inhibitor of SPP, as a control. As previously reported, 27 immunoblot analyses of cells treated with this inhibitor showed that SPP cleavage was only partially inhibited, leading to the detection of both p23 and p21. This made it possible to identify unambiguously the cleaved and uncleaved forms of the HCV core protein ( fig. 2A line 3). The core 1a protein appeared to be fully cleaved in our system, as the protein was detected solely as a 21 kDa product. A similar result was obtained with the core 1aY164F protein ( fig. 2A line 4) . We used Image J software for gel analysis to quantify the wild-type and mutant core proteins in the scanned blot and found that these two proteins were present in similar amounts.
Colocalisation of HCV core proteins with lipid droplet.
Nile red labelling in cells transfected with the -gal construct showed that lipids were evenly distributed throughout the cytoplasm ( fig. 2B ). Transfection with the core 1a construct induced the clustering of large lipid droplets in the perinuclear area. These droplets were strongly stained for HCV core protein, as previously reported for our model, 27 and for other in vitro cellular models. 20 29 The HCV core 1aY164F mutant induced a similar clustering of large lipid droplets and was distributed similarly to the core 1a protein ( fig. 2B ). Similar results were obtained when the experiment was repeated and for analyses of large numbers of cells (only one cell is shown for each construct in fig. 2B , to show the colocalisation of HCV core proteins and lipid droplets as clearly as possible). However, we cannot exclude the possibility that the HCV core 1a protein and the mutant 1aY164F protein induced subtle differences in lipid droplet clustering, undetectable by confocal microscopy. This technique was not considered appropriate for comparison and quantification of the lipid droplet accumulation induced by the two different HCV core constructs.
Electron microscopy and lipid droplet quantification
Standard electron microscopy showed that the ultrastructural changes observed in cells were consistent with the results of confocal microscopy with the clustering of large lipid droplets in the perinuclear area ( fig. 3) . No specific ultrastructural change was observed in cells producing a control protein (-Gal, not shown). Immuno-electron microscopy showed that the surface of the clustered large lipid droplets stained strongly positive for HCV core protein, as previously described in other models 19 ( fig. 3B) . Preliminary experiments suggested that the lipid droplets induced by the HCV core 1aY164F protein tended to be larger and more numerous than those induced by the HCV core 1a protein ( fig. 3) . We determined the cumulative area of these lipid droplets for 100 consecutive cell sections, for each construct, studied in random order, with the observer blind to the construct used. As expected, the cumulative area of the lipid droplets was significantly greater for the wild-type HCV core protein than for -gal (p < 0.001, fig. 4 ). This difference was accounted for mostly by the higher frequency of sections containing more than 2 m This difference was not related to HCV core protein levels or SPP cleavage. Tyrosine and phenylalanine are both aromatic, hydrophobic residues. However, phenylalanine is more hydrophobic than tyrosine, from which it differs only in terms of the hydroxyl group present in the ortho position on the benzene ring of tyrosine. Unlike tyrosine, phenylalanine has a fairly non-reactive side chain, and is thus rarely involved in protein-protein interactions. HCV core protein and lipids, rather than proteins. 33 36 The HCV core may prevent lipids from interacting with MTP, thereby inhibiting the transfer of lipids to apoB. In addition, specific interactions between HCV core protein and the lipids of the ER membrane may hamper the MTP-mediated transfer of triglycerides to the ER lumen, leading to their accumulation in lipid droplets. 33 36 The F164 residue in the HCV core 1aY164F protein may therefore confer on this mutant protein a higher affinity for the lipids in the ER membrane. Recent structural studies of the HCV core protein (1a genotype) have shown that domain II is a membrane-binding domain containing two amphipathic -helices extending from L119 to Y136 and A148 to Y164, which probably interact within the same plane at the interface of the two phospholipid layers of the ER membrane. [37] [38] [39] The tyrosine at position 164 in the HCV core protein is therefore thought to be located at the site of lipid droplet morphogenesis. 40 The replacement of this residue by a phenylalanine may increase the affinity of the HCV core protein for the
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lipids present between the leaflets of the ER membrane, ultimately leading to higher level of lipid droplet formation.
In vitro cellular models have intrinsic limitations, but our results are consistent with a hypothesis formulated on the basis of clinical studies, according to which viral sequences have a direct effect on genotype 3-specific steatosis. 9 11-15 A similar conclusion was recently drawn in a study in which an HCV core protein sequence from a genotype 3 virus was expressed in a cellular model. 24 However, the authors were unable to identify the residue(s) involved in this phenomenon, and did not implicate F164. This difference in results may be due to the different cell models and lipid droplet quantification methods used in the two studies. We believe that the method used in our study, in which lipid droplet number and size were determined in consecutive EM sections, is the most accurate way to quantify lipid accumulation in cells. However, we cannot exclude the possibility that other residues differing between the HCV core sequences used in these studies may modulate the role of the F164 in intracellular lipid accumulation. We intend to test this hypothesis in futures studies, by investigating aa changes both in the domain II and in the other HCV core protein domains.
It will also be interesting to express HCV core sequences cloned from patients infected with various genotype 3 viruses and compare their abilities to induce lipid droplet accumulation in vitro.
In conclusion, our study provides a molecular explanation for genotype 3-specific HCV-related lipid accumulation in the liver. Genotype 3 may behave differently from other genotypes due to its phenylalanine residue, which has a higher affinity for lipids than tyrosine.
It has been shown that single aa changes due to mutations in HCV core genes cloned from hepatocellular carcinoma samples can radically alter the biological activity of the protein. 41 Our study provides an additional example of the pathogenic potential of HCV core genetic variability, and may help to guide future studies of the mechanisms involved in the pathogenesis of HCV-induced liver steatosis. 
